Community pharmacists are playing an increasingly central role in chronic disease management.
Thanks to their expertise in pharmacotherapy and their proximity to their clientele, pharmacists are ideally positioned to provide this essential support. Their role includes facilitating access to care, improving the health of their patients, and potentially reducing costs for the health care system.
In pharmacy, the management of chronic diseases involves regular, personalized follow-up with patients with long-term illnesses. The purpose of these follow-ups is to monitor the efficacy and safety of treatments and to optimize therapies based on how each person's condition evolves.
This may involve adjusting the dose of a medication the patient is already taking or selecting another, more appropriate treatment. Health education is also an integral part of pharmacy care. However, as this chart from the Canadian Pharmacists Association shows, pharmacists' scope of practice varies from province to province.
In recent years, the impact of pharmacy management of various conditions has been assessed numerous times. Here are two examples of how the intervention of Canadian pharmacists has had a significant impact:
Yet, despite the critical role pharmacists play in the health care system, a number of challenges and obstacles continue to restrict their ability to treat patients with chronic diseases.
In this article, we will explore some of these challenges, as well as emerging solutions designed to support pharmacists in their mission. We'll also be talking about Chroma, a module integrated into RxConsultAction that will be launched in 2025.
Chronic disease management in community pharmacies presents a number of complex challenges. Here are just a few of them.
*Note that some tools, such as the RxIntensi-T score integrated into RxVigilance , automatically assess the complexity of pharmacological profiles, making it easier to identify patients requiring special attention.
In addition to these challenges, several other factors complicate chronic disease management in community pharmacy practice. These include:
Every obstacle requires its own solution.
The Chroma module, currently under development at Vigilance Santé, is an innovative response to the challenges of chronic disease management in community pharmacies. This new module is designed to support chronic disease management through a comprehensive set of features—data collection, therapy review, decision support, creation and updating of action plans—tailored to the specific requirements of each province.
Here's how it addresses common challenges:
- Simplified data collection. From the moment a patient's file is created, Chroma makes it easy to add information specific to their profile and chronic conditions for fast, accurate needs analysis.
- Contextualized interventions. Suggested interventions will be integrated and adapted to the patient's profile for personalized care.
- Document generation compliant with provincial requirements. Chroma will automatically generate all required documents, in line with provincial legal requirements, and simplify invoicing to lighten the administrative burden.
- Integration with pharmacy management systems (PMSs). By connecting to PMSs, Chroma will eliminate the need for duplicate data entry, another factor that will cut down on administrative tasks.
- Dynamic patient monitoring. Users will be able to update the action plan, and completed actions will be documented or archived, ensuring thorough clinical management and up-to-date data.
- Instant access to data and alerts. Leveraging the Vigilance Santé ecosystem, Chroma will provide information on drugs and clinical alerts to ensure patient safety.
For community pharmacists, providing chronic disease management services represents a commitment to improving their patients' quality of life.
However, the technological, administrative, and clinical challenges presented by this type of care are constantly evolving.
Therefore, it's encouraging to think that we will soon be able to rely on innovative solutions that will lighten the administrative burden, facilitate data management, and allow for more personalized and safer interventions.
That's why I'm delighted to contribute to Vigilance Santé's efforts to provide my peers with cutting-edge tools that will enable them to focus more on what matters most: their patients' well-being.
Join the list to receive news about Chroma & Intervention Opportunities!
This article was written with the support of some of my fellow pharmacists at Vigilance Santé: Martine Gagné, Angela Sheung Wai Chang, Julien St-Denis, Louis-Philippe Lafleur and Anthony Tétreault.
Product Director- RxVigilance, RxPhotos | Pharmacist
This blog is intended for information purposes only. The views and opinions expressed are solely those of the original authors and contributors, and do not necessarily reflect, in whole or in part, those of Vigilance Santé. Vigilance Santé makes no warranty as to the accuracy, comprehensiveness or correctness of the information contained in this blog. The information presented in this blog is in no way a substitute for professional medical advice, diagnosis, or treatment, or for the skills and expertise of a health professional. Neither Vigilance Santé (nor its shareholders, officers, directors, executives, employees, collaborators, subcontractors, and distributors) nor the authors may under any circumstances be held liable for any loss or damage directly or indirectly related to the content of this blog or its use.